In clinical trials of injectable Wegovy, people taking 2.4 mg weekly lost an average of 14.9% of their body weight in 68 weeks
Over the past few decades, extensive and in-depth research has been conducted on the molecular mechanism of DQ toxicity
The most common side effects with the 12 mg dose were nausea (43.2%), diarrhea (33.1%), constipation (25.0%), and vomiting (20.9%)
After injection, light pressure with a cotton ball is sufficient
In contrast, an activated CD16 hi NK subpopulation (CX3CR1KLRC2 CD16 hi ) with high cytotoxicity was enriched in patients who experienced favorable treatment responses
In type 2 diabetes management, combining a lower dose of GLP-1 therapy with other glucose-lowering medications (such as metformin or SGLT2 inhibitors) may achieve glycaemic targets whilst reducing side effects